In MDD, dozens of studies have linked peripheral inflammatory biomarkers—such as CRP, IL‐6, IL‐1β, IL‐8, and TNF‐α—with symptom severity and treatment response [788]. This evidence concerns the gene TNF and major depressive disorder.